Generate a tailored SOP for Dr. Carla Van Den Berg. Improve your application with a focused, well-structured draft.
Carla Van Den Berg, Pharm.D., is an accomplished Associate Professor of Pharmacology and Toxicology at the University of Colorado Health Sciences Center. Her research focuses on receptor tyrosine kinases (RTKs) and their roles in various cancers, including breast, colon, lung, and prostate cancers. Her work investigates the mechanistic insights into how RTKs propagate tumor behavior by increasing cell proliferation and migration, understanding the diverse roles of JNK proteins in cancer progression, and characterizing the molecular pathways that mediate these effects. Throughout her career, Dr. Van Den Berg has engaged in extensive research and has published numerous articles in peer-reviewed journals, contributing to the field of cancer pharmacology. She has received several grants to fund her research projects and has been recognized with multiple awards for her contributions to clinical pharmacy and oncology research. Dr. Van Den Berg’s dual involvement in academic teaching and research reflects her dedication to advancing knowledge in cancer therapeutics and training future pharmacists in specialized knowledge areas such as oncology. She continues to be an influential figure within the academic community in her respective fields.
University of Colorado Health Sciences Center • Denver, Colorado
Serves as an associate professor and co-director of the Developmental Therapeutics Lab.
College of Pharmacy, University of Texas • Austin, Texas
Contributes to teaching and research in pharmacology and toxicology.
General requirements for the Graduate School at UT Austin apply to all programs unless otherwise specified.